At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Closed Loop Insulindevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Feasibility of Fully Automated Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation
In Brief
A clinical study evaluating Closed Loop Insulin for Chronic Pancreatitis and Diabetes Mellitus. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effectiveness of closed loop insulin pump therapy to control blood sugar following total pancreatectomy and islet auto-transplantation (TPIAT).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pancreatitis, Diabetes Mellitus
CountriesUnited States
CollaboratorsMedtronic MiniMed, Inc.
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 2013
Enrollment StartFeb 2014
Primary CompletionJun 2015
Study CompletionDec 2015
TodayJul 2026
First PostedSep 18, 2013
Enrollment StartFeb 1, 2014
Primary CompletionJun 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.8 years ago
Interventions
Closed Loop Insulindevice
The Closed Loop Insulin system is an automated insulin delivery system based on body blood glucose. It consists of an Insulin pump, continuous glucose monitor, and a control device (laptop with algorithms).